• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength.三体:具有高稳定性和显著提高的靶标结合强度的稳健自组装三聚体靶向配体。
Biochemistry. 2013 Oct 15;52(41):7283-94. doi: 10.1021/bi400716w. Epub 2013 Oct 3.
2
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.白蛋白结合 PSMA 配体:组织分布特征的优化。
Mol Pharm. 2018 Mar 5;15(3):934-946. doi: 10.1021/acs.molpharmaceut.7b00877. Epub 2018 Feb 5.
3
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.新型 PSMA 靶向放射性配体的临床前开发:调节白蛋白结合特性以改善前列腺癌治疗。
Mol Pharm. 2018 Jun 4;15(6):2297-2306. doi: 10.1021/acs.molpharmaceut.8b00152. Epub 2018 May 2.
4
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands.建立前列腺癌细胞内化过程模型用于 PSMA 特异性配体
Nucl Med Biol. 2019 May-Jun;72-73:20-25. doi: 10.1016/j.nucmedbio.2019.05.003. Epub 2019 May 29.
5
Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.含多柔比星的 PSMA 靶向缀合物的合成与生物学评价。
Bioorg Med Chem Lett. 2019 May 15;29(10):1246-1255. doi: 10.1016/j.bmcl.2019.01.040. Epub 2019 Feb 1.
6
Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.针对 BCL-2 和 EGFR 的双特异性反义寡核苷酸处理后 LNCaP 细胞中分化的前列腺抗原表达。
Med Oncol. 2012 Jun;29(2):835-41. doi: 10.1007/s12032-011-9977-x. Epub 2011 May 15.
7
Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR.经针对 bcl-2 和 EGFR 的双特异性反义寡核苷酸处理后,LNCaP 细胞中前列腺特异性膜抗原表达增加。
Med Oncol. 2010 Dec;27(4):1212-8. doi: 10.1007/s12032-009-9361-2. Epub 2009 Nov 24.
8
Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).靶向人前列腺特异性膜抗原(PSMA)的抗钙素的筛选与鉴定
Protein Eng Des Sel. 2016 Mar;29(3):105-15. doi: 10.1093/protein/gzv065. Epub 2016 Jan 21.
9
Heptameric targeting ligands against EGFR and HER2 with high stability and avidity.具有高稳定性和亲和力的针对 EGFR 和 HER2 的七聚体靶向配体。
PLoS One. 2012;7(8):e43077. doi: 10.1371/journal.pone.0043077. Epub 2012 Aug 9.
10
Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of Ga, In, Lu and Ac.评估携带新型螯合物的PSMA靶向配体在诊疗学中的应用:镓、铟、镥和锕的稳定性及络合动力学
Nucl Med Biol. 2017 Dec;55:38-46. doi: 10.1016/j.nucmedbio.2017.10.001. Epub 2017 Oct 3.

引用本文的文献

1
Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.可定制设计的多聚体以一种对变体不敏感的方式中和 SARS-CoV-2。
Front Immunol. 2023 Aug 10;14:1226880. doi: 10.3389/fimmu.2023.1226880. eCollection 2023.
2
Targeted Delivery of In Into the Nuclei of EGFR Overexpressing Cells Modular Nanotransporters With Anti-EGFR Affibody.通过具有抗表皮生长因子受体(EGFR)亲和体的模块化纳米转运体将铟靶向递送至EGFR过表达细胞的细胞核。
Front Pharmacol. 2020 Mar 4;11:176. doi: 10.3389/fphar.2020.00176. eCollection 2020.
3
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis.脂多糖的捕获促进结直肠癌的免疫治疗并减轻肝转移。
Adv Mater. 2018 Dec;30(52):e1805007. doi: 10.1002/adma.201805007. Epub 2018 Nov 2.
4
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.免疫原性化疗和局部表达 PD-L1 陷阱协同作用且不良反应低的癌症免疫疗法。
Nat Commun. 2018 Jun 8;9(1):2237. doi: 10.1038/s41467-018-04605-x.
5
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.纳米颗粒介导的 Wnt 家族成员 5A 在肿瘤微环境中的捕获增强了 B-Raf 原癌基因突变型黑色素瘤的免疫治疗。
ACS Nano. 2018 Feb 27;12(2):1250-1261. doi: 10.1021/acsnano.7b07384. Epub 2018 Jan 31.
6
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer.趋化因子和免疫检查点陷阱的瞬时和局部表达治疗胰腺癌。
ACS Nano. 2017 Sep 26;11(9):8690-8706. doi: 10.1021/acsnano.7b01786. Epub 2017 Aug 28.
7
Modular protein domains: an engineering approach toward functional biomaterials.模块化蛋白质结构域:一种构建功能性生物材料的工程方法。
Curr Opin Biotechnol. 2016 Aug;40:56-63. doi: 10.1016/j.copbio.2016.02.011. Epub 2016 Mar 9.

本文引用的文献

1
Generation and characterization of monospecific and bispecific hexavalent trimerbodies.单特异性和双特异性六价三聚体抗体的产生和鉴定。
MAbs. 2013 Jan-Feb;5(1):70-9. doi: 10.4161/mabs.22698. Epub 2012 Dec 5.
2
Antibody-drug conjugates in cancer therapy.抗体药物偶联物在癌症治疗中的应用。
Annu Rev Med. 2013;64:15-29. doi: 10.1146/annurev-med-050311-201823. Epub 2012 Oct 3.
3
PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.聚乙二醇化 PRINT 纳米颗粒:聚乙二醇密度对蛋白结合、巨噬细胞关联、生物分布和药代动力学的影响。
Nano Lett. 2012 Oct 10;12(10):5304-10. doi: 10.1021/nl302638g. Epub 2012 Sep 5.
4
Heptameric targeting ligands against EGFR and HER2 with high stability and avidity.具有高稳定性和亲和力的针对 EGFR 和 HER2 的七聚体靶向配体。
PLoS One. 2012;7(8):e43077. doi: 10.1371/journal.pone.0043077. Epub 2012 Aug 9.
5
Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.包含人胶原蛋白XV三聚化结构域的多价抗体的稳定性提高。
MAbs. 2012 Mar-Apr;4(2):226-32. doi: 10.4161/mabs.4.2.19140. Epub 2012 Mar 1.
6
Designed cyclic permutants of HIV-1 gp120: implications for envelope trimer structure and immunogen design.设计的 HIV-1 gp120 环状置换物:对包膜三聚体结构和免疫原设计的影响。
Biochemistry. 2012 Mar 6;51(9):1836-47. doi: 10.1021/bi300003v. Epub 2012 Feb 22.
7
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.通过利用 APRIL 靶向 HIV-1 包膜糖蛋白三聚体至 B 细胞可改善抗体应答。
J Virol. 2012 Mar;86(5):2488-500. doi: 10.1128/JVI.06259-11. Epub 2011 Dec 28.
8
Prostate-specific membrane antigen-based therapeutics.基于前列腺特异性膜抗原的疗法。
Adv Urol. 2012;2012:973820. doi: 10.1155/2012/973820. Epub 2011 Jul 17.
9
The matrilins: modulators of extracellular matrix assembly.基质连接蛋白:细胞外基质组装的调节蛋白。
Int J Biochem Cell Biol. 2011 Mar;43(3):320-30. doi: 10.1016/j.biocel.2010.12.010. Epub 2010 Dec 14.
10
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1.PH1 衍生的二价双抗体和三价三抗体与脱落和肿瘤细胞相关的 MUC1 结合具有差异性。
Protein Eng Des Sel. 2010 Sep;23(9):721-8. doi: 10.1093/protein/gzq044. Epub 2010 Jul 8.

三体:具有高稳定性和显著提高的靶标结合强度的稳健自组装三聚体靶向配体。

Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength.

机构信息

Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina , Chapel Hill, North Carolina 27599-7568, United States.

出版信息

Biochemistry. 2013 Oct 15;52(41):7283-94. doi: 10.1021/bi400716w. Epub 2013 Oct 3.

DOI:10.1021/bi400716w
PMID:24050811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3851414/
Abstract

The C-terminal coiled-coil region of mouse and human cartilage matrix protein (CMP) self-assembles into a parallel trimeric complex. Here, we report a general strategy for the development of highly stable trimeric targeting ligands (tribodies), against epidermal growth factor receptor (EGFR) and prostate-specific membrane antigen (PSMA) as examples, by fusing a specific target-binding moiety with a trimerization domain derived from CMP. The resulting fusion proteins can efficiently self-assemble into a well-defined parallel homotrimer with high stability. Surface plasmon resonance (SPR) analysis of the trimeric targeting ligands demonstrated significantly enhanced target-binding strength compared with the corresponding monomers. Cellular-binding studies confirmed that the trimeric targeting ligands have superior binding strength toward their respective receptors. Significantly, the EGFR-binding tribody was considerably accumulated in the tumor of mice bearing xenografted EGFR-positive tumors, indicating its effective cancer-targeting feature under in vivo conditions. Our results demonstrate that CMP-based self-assembly of tribodies can be a general strategy for the facile and robust generation of trivalent targeting ligands for a wide variety of in vitro and in vivo applications.

摘要

鼠和人软骨基质蛋白(CMP)的 C 端卷曲螺旋区自行装配成平行的三聚体复合物。在这里,我们报告了一种通用策略,用于开发高度稳定的三聚体靶向配体(tribody),以表皮生长因子受体(EGFR)和前列腺特异性膜抗原(PSMA)为例,将特定的靶结合部分与源自 CMP 的三聚体化结构域融合。所得融合蛋白可以有效地自我组装成具有高稳定性的定义良好的平行同源三聚体。表面等离子体共振(SPR)分析表明,与相应的单体相比,三聚体靶向配体的靶结合强度显著增强。细胞结合研究证实,三聚体靶向配体对各自的受体具有更高的结合强度。值得注意的是,EGFR 结合的 tribody 在携带异种移植 EGFR 阳性肿瘤的小鼠肿瘤中大量积累,表明其在体内条件下具有有效的癌症靶向特征。我们的结果表明,基于 CMP 的 tribody 自组装可以成为一种通用策略,用于方便、有效地生成各种用于体外和体内应用的三价靶向配体。